Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Cipla
Covington
McKinsey
US Department of Justice
Express Scripts
Mallinckrodt
McKesson
Daiichi Sankyo

Generated: December 13, 2018

DrugPatentWatch Database Preview

Drug Price Trends for METHAZOLAMIDE

« Back to Dashboard

Drug Price Trends for METHAZOLAMIDE

Average Pharmacy Cost for METHAZOLAMIDE

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
METHAZOLAMIDE 50 MG TABLET 62559-0241-01 5.30745 EA 2018-11-21
METHAZOLAMIDE 50 MG TABLET 00574-0791-01 5.30745 EA 2018-11-21
METHAZOLAMIDE 50 MG TABLET 00781-1071-01 5.30745 EA 2018-11-21
METHAZOLAMIDE 25 MG TABLET 00574-0790-01 3.00763 EA 2018-10-17
Drug Name NDC Price/Unit ($) Unit Date

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Best Wholesale Price for METHAZOLAMIDE

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
METHAZOLAMIDE 25MG TAB Perrigo Sourcing Solutions, Inc. 00574-0790-01 100 172.90 1.72900 EA 2018-10-01 - 2023-09-30 FSS
METHAZOLAMIDE 50MG TAB Perrigo Sourcing Solutions, Inc. 00574-0791-01 100 345.61 3.45610 EA 2018-10-01 - 2023-09-30 FSS
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Teva
Dow
Queensland Health
Daiichi Sankyo
Baxter
Mallinckrodt
Covington
Merck
QuintilesIMS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.